News

Congress Leaves Town with Major Drug-Related Bills on Hold

July 28, 2023

Pandemic, PBM, and other policies on hold during the summer recess.

Biovian Invests €50 Million in Manufacturing Facility in Finland

July 28, 2023

The expansion project is aimed to be completed in December 2024 and the new facility will be fully operational by 2025.

Teva Pharmaceuticals and Alvotech Expand Existing Biosimilars Partnership

July 27, 2023

Teva Pharmaceuticals and Alvotech will expand their partnership for the development and commercialization of biosimilar candidates.

Roche and Alnylam Strike $2.8 Billion RNAi Deal

July 27, 2023

Roche will pay up to $2.8 billion for the rights to Alnylam’s RNA-based hypertension therapeutic.

FDA Approves Novel Demodex Blepharitis Treatment

July 27, 2023

Tarsus Pharmaceuticals’ Xdemvy (lotilaner ophthalmic solutions) is designed to treat Demodex blepharitis by directly targeting Demodex mites.

EMA Gives Positive Opinion on Two of Janssen’s Bispecific Antibodies

July 27, 2023

Janssen has received a positive opinion from the EMA for two novel bispecific antibodies, TALVEY (talquetamab) and TECVAYLI (teclistamab), which the company is developing to treat blood cancer.

MilliporeSigma Expands Production Facility for Cell Culture Media

July 27, 2023

MilliporeSigma has invested $25 million to expand its cell culture media production facility in Lenexa, Kan.

AbbVie Expands Collaboration with Calibr to Advance Clinical Assets

July 27, 2023

The partnership is an extension of the collaboration from AbbVie and Scripps Research that was formed in 2019, according to the press release.

Update on Storm Damage to Pfizer Facility in North Carolina

July 25, 2023

The damage to the facility, which produces 8% of US injectable drug consumption, should not significantly affect the current supply.

EMA Extends OPEN Framework to More Medicines

July 24, 2023

The framework is now expanded beyond COVID-19 vaccines and treatments.